đź“°Zero Tariffs? | Daily India Briefing

Three stories on Indian markets that you can't miss.

In partnership with

Trump said that India has offered to reduce tariffs to zero, reopening trade talks. India eyes new markets for its pharma exports. India panel calls for steep increases on taxes on luxury electric vehicles.

If you have any questions about India, fill out this form or reach out to Shreyas at [email protected]

Macro

Equities

Alts

Policy

Looking for unbiased, fact-based news? Join 1440 today.

Join over 4 million Americans who start their day with 1440 – your daily digest for unbiased, fact-centric news. From politics to sports, we cover it all by analyzing over 100 sources. Our concise, 5-minute read lands in your inbox each morning at no cost. Experience news without the noise; let 1440 help you make up your own mind. Sign up now and invite your friends and family to be part of the informed.

Reach out to [email protected] to reach our audience and see your advertisement here.

1. India Offered to Reduce Tariffs to Zero

India has offered to reduce tariffs on U.S. goods to zero, a move that could reopen the door to trade negotiations even as Washington’s steep duties on Indian exports take effect.

In a social media post on Monday, Trump claimed New Delhi’s concession came “too late” and should have been made “years ago.” Still, the remarks suggest some scope for talks after months of escalating tensions.

India’s Commerce Minister Piyush Goyal echoed that sentiment on Tuesday, saying both sides were “in dialog” for a bilateral trade agreement. Formal negotiations remain on hold after a U.S. team canceled its August trip to New Delhi, but officials have kept informal communication channels open.

Trump imposed tariffs of up to 50 percent on Indian exports to punish the country for what he called “obnoxious” trade barriers and its increased purchases of Russian oil. India had previously offered to cut levies on industrial goods such as auto components and pharmaceuticals if Washington reciprocated. Talks broke down, however, over U.S. demands to open India’s sensitive dairy and agriculture markets.

Analysts say Trump’s latest comments may signal a shift toward compromise. “This is his attempt to walk back on his earlier hardened stance,” said Abhijit Das, a former Indian trade official.

For now, both countries appear reluctant to let the dispute derail ties entirely, with negotiators still searching for common ground.

2. India Eyes New Pharma Markets

Prescription drugs on an orange background with a pill bottle. Orange pills.

India is preparing to expand pharmaceutical exports to Russia, Brazil and the Netherlands, according to industry sources, in a push to reduce reliance on the U.S., its biggest market. India will raise regulatory issues with these countries at next month’s International Pharmaceutical Exhibition in New Delhi, where global regulators are to attend.

India is the world’s largest provider of generic medicines by volume, estimated at $50 billion in FY2024, and is often referred to as the “pharmacy of the world.” It is the 11th largest exporter of pharmaceutical products in dollar-value.

Currently, the U.S. accounts for over one-third of India’s pharma exports, with shipments up 20 percent in FY25 to $10.5 billion (₹924.7 billion), mainly driven by demand for cheaper generics. By contrast, exports to Brazil totaled $778 million (₹68.5 billion), the Netherlands $616 million (₹54.2 billion), and Russia $577 million (₹50.8 billion). Officials see room to lift sales in these markets by as much as 20 percent, helped by existing spare manufacturing capacity. The UK, India’s second-largest pharma market at $914 million (₹80.5 billion), also remains a focus, with expectations of a boost in NHS procurement following the free trade agreement signed earlier this year.

Still, analysts caution that no other market can match the scale of the U.S., making diversification additive rather than substitutive.

3. India Tax Panel Calls for Steep Levies on Luxury EVs

An Indian tax panel has recommended steep increases in levies on luxury electric vehicles, a move that could deal a blow to global automakers such as Tesla, BMW, Mercedes-Benz, and BYD just as they seek to expand in the country.

The panel, which advises the powerful Goods and Services Tax (GST) Council, proposed raising the GST rate on EVs priced between $23,000–$46,000 (₹2-4 million) to 18 percent from the current 5 percent. For vehicles priced above $46,000 (₹4 million), it suggested lifting the rate to 28 percent, arguing such cars cater to the “upper segment” of society and are largely imported.

The proposals come as Modi pushes through sweeping tax reforms aimed at boosting domestic consumption and curbing luxury imports. While his government is eliminating the 28 percent GST tier for most goods, officials may carve out a new 40 percent bracket for certain luxury products, which could further squeeze high-end EVs, according to a government source.

India’s EV market remains small, just 5 percent of car sales in April–July, but demand is growing rapidly, with sales nearly doubling to 15,500 units. Tesla only recently opened showrooms in India, with its Model Y priced from $65,000, while Mercedes and BMW are expanding their portfolios.

Automakers are warning that tax hikes could slow adoption. “It is imperative the 5 percent rate is retained,” Tata Motors said, while BMW and Mercedes cautioned that steeper levies risk derailing India’s clean-mobility ambitions.

See you tomorrow.

Written by Eshaan Chanda & Yash Tibrewal. Edited by Shreyas Sinha.

Sponsor the next newsletter to reach tens of thousands of U.S.-based business-savvy professionals. Reach out to [email protected].

Could your business use expert insights to power growth in India? Reach out to [email protected] for a free introductory call.

Disclaimer: This is not financial advice or recommendation for any investment. The Content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.